General Information of DTT (ID: TTDNFMT)

DTT Name Platelet-activating factor acetylhydrolase (PLA2G7) DTT Info
UniProt ID
PAFA_HUMAN
Gene Name PLA2G7

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
Patented Agent(s)
Investigative Drug(s)
Discontinued Drug(s)
2 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
GSK2647544 DM3KARJ Alzheimer disease 8A20 Phase 1 [1]
Rilapladib DMB9861 Arteriosclerosis BD40 Phase 1 [2], [3]
------------------------------------------------------------------------------------
2 Patented Agent(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Bicyclic pyrimidine derivative 2 DMJP16K N. A. N. A. Patented [4]
Indolizine derivative 1 DM4GZBI N. A. N. A. Patented [4]
------------------------------------------------------------------------------------
3 Discontinued Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
RPAF-AH DMOVJ60 Sepsis 1G40-1G41 Discontinued in Phase 3 [5]
Goxalapladib DMSGUY9 Arteriosclerosis BD40 Discontinued in Phase 1 [6]
GSK568859 DM6E84O Arteriosclerosis BD40 Discontinued in Phase 1 [1]
------------------------------------------------------------------------------------
6 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
(1r)-1,2,2-trimethylpropyl (r)-methylphosphinate DMVE34H Discovery agent N.A. Investigative [7]
(E)-(thiophen-2-ylmethylidene)amino benzoate DMHSJAT Discovery agent N.A. Investigative [8]
3,4-difluorobenzaldehyde O-benzoyloxime DMFV3Y9 Discovery agent N.A. Investigative [9]
4-fluorobenzaldehyde O-benzoyloxime DM2N4BJ Discovery agent N.A. Investigative [9]
Benzaldehyde O-benzoyloxime DMB7DFT Discovery agent N.A. Investigative [9]
SB-381320 DM3BV5S Discovery agent N.A. Investigative [8]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Investigative Drug(s)
Molecule Interaction Atlas

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1432).
2 Phospholipase A2 inhibitors. Curr Opin Lipidol. 2009 Aug;20(4):327-32.
3 THERAPEUTICS: Rilapladib
4 Inhibitors of phospholipase A2 and their therapeutic potential: an update on patents (2012-2016).Expert Opin Ther Pat. 2017 Feb;27(2):217-225.
5 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800006777)
6 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800020582)
7 The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
8 (E)-Phenyl- and -heteroaryl-substituted O-benzoyl-(or acyl)oximes as lipoprotein-associated phospholipase A2 inhibitors. Bioorg Med Chem Lett. 2005 Mar 1;15(5):1525-7.
9 Potent inhibitors of lipoprotein-associated phospholipase A(2): benzaldehyde O-heterocycle-4-carbonyloxime. Bioorg Med Chem Lett. 2006 Nov 1;16(21):5576-9.